Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients

E Blodget1, P Jan Geiseler, R A Larsen

  • 1Division of Infectious Diseases, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA. eblodget@usc.edu

Insights

Disseminated coccidioidomycosis occurred in 3 organ recipients from an infected donor. Early serologic testing for Coccidioides immitis in organ donors from endemic areas is crucial for preventing transmission.

Area of Science:

  • Infectious Diseases
  • Transplantation Immunology
  • Mycology

Background:

  • Organ transplantation carries a risk of infectious disease transmission.
  • Coccidioidomycosis is a fungal infection endemic to specific regions.
  • Undiagnosed infections in donors can lead to severe outcomes in recipients.

Observation:

  • Three organ transplant recipients developed disseminated coccidioidomycosis.
  • The infection was traced to a donor with unrecognized meningeal coccidioidomycosis.
  • All recipients presented with symptoms within three weeks post-transplantation.

Findings:

  • Only one of the three organ recipients survived the acute phase of coccidioidomycosis.
  • The donor's meningeal infection was a source of disseminated disease in recipients.
  • Rapid onset of severe symptoms was observed in the transplant recipients.

Implications:

  • Routine serologic screening for Coccidioides immitis in organ donors from endemic areas is recommended.
  • Early detection and management of fungal infections in donors can prevent post-transplant complications.
  • This case highlights the importance of donor screening for endemic mycoses in transplantation.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview